FDA Approves New Weight-Loss Drug

FDA Approves New Weight-Loss Drug

The oral weight-loss drug lorcaserin hydrochloride (Belviq) has been approved as an adjunct to diet and exercise in obese patients as well as in those who are overweight and have at least one other weight-related disorder such as hypertension. See this week’s Item #2, FDA Approves Lorcaserin (Belvig) for Treatment of Obesity, for more details.